Other languages Notable Labs, Ltd.

Equities

NTBL

IL0012002452

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
0.9601 ^USD	-2.13%		-1.02%	-49.20%

Apr. 15	Chardan Cuts Price Target on Notable Labs to $7 From $9, Keeps Buy Rating	MT
Apr. 15	Chardan Cuts Price Target on Notable Labs to $7 From $9 on Higher Projected Future Share Count, Keeps Buy Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Notable Labs, Ltd. Presents the Design Plan for the Ppmp-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024	Apr. 09
Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay At AACR 2024 Expands the Potential of the Platform	Apr. 08
OPINIONES DE LOS ANALISTAS DEL DÍA : Stellantis, Aena, Richemont, Adyen, Fraport, BBVA, Aperam, Enagás, Sacyr, BE Semi...	Apr. 02
Notable Labs, Ltd. Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment	Feb. 22
Top Premarket Gainers	Jan. 09
Notable Labs, Ltd. and CicloMed LLC Announces Initial Safety and Efficacy Data of Fosciclopirox and the Performance of PPMP	Dec. 18
Vascular Biogenics, Notable Labs Complete Merger	23-10-16
Notable Labs, Inc. completed the acquisition of Vascular Biogenics Ltd. from Aurum Ventures MKI Ltd. and others in reverse merger transaction.	23-10-15
Vascular Biogenics Ltd. Approves Board Appointments	23-10-12
Vascular Biogenics Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Vascular Biogenics Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Vascular Biogenics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14
An unknown buyer completed the acquisition of Manufacturing facility in Modiin, Israel and certain related assets from Vascular Biogenics Ltd..	23-03-08
Aleph Farms Limited completed the acquisition of manufacturing facility in Israel from Vascular Biogenics Ltd..	23-03-08
Sector Update: Health Care Stocks Finishing with Small Rise	23-02-23
Sector Update: Health Care	23-02-23
Top Midday Gainers	23-02-23
Vascular Biogenics, Notable Labs Sign Merger to Form Nasdaq-Listed Therapeutic Platform Company	23-02-23
Sector Update: Health Care Stocks Decline Late Thursday	23-02-16
Vascular Biogenics Sells Manufacturing Facility, Related Assets for $7.1 Million	23-02-16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Notable Labs, Ltd.

Equities

NTBL

IL0012002452

Other languages

Filters